(93 days)
Not Found
No
The description focuses on the physical components and performance characteristics of a laser fiber, with no mention of AI or ML.
Yes
The device is intended for use in laser-based surgical applications for vaporization, ablation, fragmentation, hemostasis, excision, resection, and incision of various tissues and calculi, which are therapeutic actions.
No
The device is described as an energy delivery device for laser-based surgical applications involving vaporization, ablation, and fragmentation, and it does not mention any diagnostic functions.
No
The device description explicitly details physical components such as a stainless steel connector, aluminum expansion nut, optical fiber, and protective jacket, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device used in surgical procedures for vaporization, ablation, fragmentation, hemostasis, excision, resection, and incision of tissues and calculi. This is a direct surgical intervention, not a diagnostic test performed on samples taken from the body.
- Device Description: The device is a fiber optic energy delivery system designed to transmit laser energy for surgical purposes. It does not involve the analysis of biological samples.
- Lack of IVD Characteristics: There is no mention of analyzing biological specimens (blood, urine, tissue samples, etc.) or providing diagnostic information about a patient's health status.
IVD devices are used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This device's function is to deliver energy for surgical procedures, which falls outside the scope of IVD.
N/A
Intended Use / Indications for Use
Proflex™ Laser Fibers are intended for use in laser-based surgical applications including, but not limited to endoscopic, laparoscopic and open surgical procedures involving vaporization, ablation and fragmentation of calculi (urinary and biliary) and surgical procedures involving vaporization, ablation, coagulation, hemostasis, excision, resection and incision and of soft and cartilaginous tissues. While designed primarily for holmium (Ho:YAG) lasers, ProFlex™ fibers may be used with any laser wavelength between 500nm and 2200nm that have been cleared for surgical use including, but not limited to frequency doubled Nd:YAG (KTP) lasers, argon lasers, diode lasers, alexandrite lasers, ruby lasers, dye lasers, Nd:YAG lasers and Tm:YAG lasers.
Product codes (comma separated list FDA assigned to the subject device)
GEX
Device Description
The ProFlex™ Laser Fibers are fiber optic energy delivery devices consisting of a stainless steel laser connector, e.g. SMA 905, an anodized aluminum expansion nut, strain relief, doubly step index clad optical fiber (fluoroacrylate over fluorine doped fused silica) with an ethylene tetrafluorethylene (ETFE, Tefzel™) protective jacket and are available in two fiber core diameters: 200µm & 273µm. The ProFlex™ Laser Fibers are equipped with laser launch overfill protection (spatial and angular) -- a protective, transmissive quartz ferrule, fused about the fiber input face and laser polished for high damage threshold (laser and physical), and ruggedized output tips designed for ease of transit in flexible ureteroscopes. All materials of construction are USP Class VI biocompatible and compatible with flash autoclave and EtO sterilization.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The performance of ProFlex™ 200 fibers were compared to SureFlex™ LLF200TG for the 200um core fiber design. The ProFlex 273 fibers were compared to Laser Peripherals HB200. Subject and predicate fibers were power tested in relaxed and strained (bending) configurations using a cleared surgical holmium laser. ProFlex™ Laser Fibers performed better than the predicate devices in all four cases -- 200µm core ProFlex™ versus 200µm core SureFlex™, relaxed and stressed, and 273um core ProFlex™ versus 273um core Laser Peripherals, relaxed and stressed - individually, on average and in consistency. Accordingly, ProFlex™ fibers are determined to be as safe and as effective as the predicate devices. ProFlex has also been evaluated by one OEM holmium laser manufacturer and found to preform well.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized human figure.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 19, 2014
InnovaQuartz LLC Mr. Stephen Griffin Vice President for Engineering, Research and Development 23030 North 15th Avenue Phoenix, Arizona 85027
Re: K142638
Trade/Device Name: Proflex™ Laser Fibers (Proflex 200 and Proflex 273) Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: Class II Product Code: GEX Dated: September 29, 2014 Received: October 1, 2014
Dear Mr. Griffin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
1
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Binita S. Ashar -S
Binita S. Ashar, M.D., M.B.A., F.A.C.S. Director Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
| 510(k) Number (if known) | |
|---|---|
| -------------------------- | -- |
Device Name
ProFlexTM Laser Fibers (ProFlex 200 and ProFlex 273)
Indications for Use (Describe)
Proflex™ Laser Fibers are intended for use in laser-based surgical applications including, but not limited to endoscopic, laparoscopic and open surgical procedures involving vaporization, ablation and fragmentation of calculi (urinary and biliary) and surgical procedures involving vaporization, ablation, hemostasis, excision, resection and incision and of soft and cartilaginous tissues. While designed primarily for holmium (Ho: YAG) lasers, ProFlex™ fibers may be used with any laser wavelength between 500nm and 2200mm that have been cleared for surgical use including, but not limited to frequency doubled Nd: YAG (KTP) lasers, argon lasers, alexandrite lasers, ruby lasers, dye lasers, Nd:YAG lasers and Tm:YAG lasers.
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image is a logo for IQ LLC InnovaQuartz. The logo is blue and red. The letters "IQ LLC" are in blue, with a red swirl around the "IQ". The word "InnovaQuartz" is in a smaller font below the "IQ LLC".
23030 North Fifteenth Avenue Phoenix, Arizona 85027-1315 623-434-1895 innovaquartz.com
510(k) Summary
Sponsor/Owner/Holder:
InnovaQuartz LLC 23030 N 15th Ave Phoenix, AZ 85027-1315 623-434-1895
Contact:
Stephen Griffin VP Engineering, R&D 623-434-1895 (main) x101 623-229-5174 mobile steveg@innovaquartz.com
Registration:
At the time of this writing, the establishment registration fee has been paid
Device Name:
| Trade Name: | ProFlex™ Laser Fibers |
|---|---|
| ProFlex™ 200 (P/Ns: S-LLF200TL, R-LLF200TL) | |
| ProFlex™ 273 (P/Ns: S-LLF273TL, R-LLF273TL) | |
| Common Name: | Laser Instrument, Surgical, Powered |
| Classification: | Laser surgical instrument for use in general and plastic |
| surgery and in dermatology (21CFR 878.4810, Product | |
| Code GEX, Class II) | |
| Panel: | General and Plastic Surgery |
Legally Marketed Predicate Device(s):
| Trade Name: | Laser Peripherals Holmium Bare Fibers
Specifically model HB-200 |
|---------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Common Name:
Classification: | Laser Instrument, Surgical, Powered
GEX - Laser surgical instrument for use in general
and plastic surgery and in dermatology – 21 CFR
878.4810, Class II |
| 510(k) Number: | K972272 issued to Laser Peripherals, Inc., 1000
Boone Ave. North, Suite 300, Golden Valley, MN |
| | AND |
| Trade Name: | SureFlex™ and AccuFlex™ Laser Lithotripsy Fibers
specifically model LLF200TG |
| Common Name: | Laser Instrument, Surgical, Powered |
4
| Classification: | GEX – Laser surgical instrument for use in general
and plastic surgery and in dermatology – 21 CFR
878.4810, Class II |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 510(k) Number: | K050108 awarded to InnovaQuartz Incorporated,
23030 N 15th Ave, Phoenix, AZ 85027 and now held
by AMS Innovation Center, 3070 Orchard Dr, San
Jose, CA 95134 |
Device Description:
The ProFlex™ Laser Fibers are fiber optic energy delivery devices consisting of a stainless steel laser connector, e.g. SMA 905, an anodized aluminum expansion nut, strain relief, doubly step index clad optical fiber (fluoroacrylate over fluorine doped fused silica) with an ethylene tetrafluorethylene (ETFE, Tefzel™) protective jacket and are available in two fiber core diameters: 200µm & 273µm. The ProFlex™ Laser Fibers are equipped with laser launch overfill protection (spatial and angular) -- a protective, transmissive quartz ferrule, fused about the fiber input face and laser polished for high damage threshold (laser and physical), and ruggedized output tips designed for ease of transit in flexible ureteroscopes. All materials of construction are USP Class VI biocompatible and compatible with flash autoclave and EtO sterilization.
Intended Use:
Proflex™ Laser Fibers have the same indications for use as the predicate SureFlex™ and AccuFlex™ Laser Lithotripsy Fibers:
Proflex™ Laser Fibers are intended for use in laser-based surgical applications including, but not limited to endoscopic, laparoscopic and open surgical procedures involving vaporization, ablation and fragmentation of calculi (urinary and biliary) and surgical procedures involving vaporization, ablation, coagulation, hemostasis, excision, resection and incision and of soft and cartilaginous tissues. While designed primarily for holmium (Ho:YAG) lasers, ProFlex™ fibers may be used with any laser wavelength between 500nm and 2200nm that have been cleared for surgical use including, but not limited to frequency doubled Nd:YAG (KTP) lasers, argon lasers, diode lasers, alexandrite lasers, ruby lasers, dye lasers, Nd:YAG lasers and Tm:YAG lasers.
Differences in the indications for use between ProFlex™ and the Laser Peripherals Holmium Bare Fibers predicate are limited to the range of laser wavelengths for which compatibility is identified. Laser Peripherals
5
lists the two most common wavelengths for which low [OH] fused silica core optical fiber is used in surgical applications while ProFlex™ SureFlex™ and AccuFlex™ specify the spectral region of compatibility and offer examples of surqical lasers operating within this range including, but not limited to, the two lasers identified in the Laser Peripherals predicate device indications for use.
Technological Characteristics:
The ProFlex™ Iine of fiber optic energy delivery devices is similar to Laser Peripherals Holmium Bare Fibers in materials of construction and indications for use and is identical to the SureFlex™ and AccuFlex™ predicate devices in materials, methods of construction, indications for use and minimum performance criteria.
The principal differentiating characteristics of ProFlex™ versus the Laser Peripherals predicate device lie in the techniques employed for tolerance of fiber core overfill and in output tip formation. Laser Peripherals exploits the standard "fiber well" termination, also known as "high power" terminations in the art, where the connector face is counter-bored for a depth of millimeters to remove adhesive and connector materials from the focal plane and immediate vicinity of the laser focal spot. ProFlex™ utilizes a transparent (transmissive) fused quartz ferrule, positioned about the fiber diameter at the proximal terminus and fused to the fiber to space the fiber core apart from adhesive or connector materials at the focal plane.
ProFlex™ (like SureFlex™ and AccuFlex™) presents a laser polished input face to the laser aperture for a maximum damage threshold surface (physical and mechanical) that is easily cleaned, versus the Laser Peripherals exposed, thin and mechanically polished, flat fiber face. Fibers with core diameters that are on the order of, or smaller than, the laser focal spot diameter are up-tapered for ProFlex™ and the SureFlex/AccuFlex predicate devices such that the fiber core presented to the laser focus is as large or larger than the laser focal spot diameter. Rather than spilling spatial overfill energy onto the fiber connector or reflecting the energy back into the laser aperture, ProFlex™ (like the SureFlex(/AccuFlex predicate) captures spatial overfill and delivers the energy into the fiber optic conduit.
The differences between these two fiber designs are: the fiber taper ratio (input core diameter), the length of the transmissive ferrule and the
6
position of the brass crimp at the distal terminus of the transmissive ferrule. These design differences result for over a decade of experience with the true optical characteristics of approved surgical laser foci and improved assembly strategies for higher concentricity of the fiber within the connector body that, combined, permit the use of smaller taper ratios.
Laser Peripherals employs a mechanical polish for the output tip that is produced on a stripped (ETFE) section of approximately 5mm to 8mm long where ProFlex™ utilizes a laser to vaporize and melt the output tip into a small, slightly convex and aspheric output on a section of stripped of ETFE 3mm to 4mm long. The sharp, 90 degree edge of the mechanically polished fiber tip (for the predicate LP device) is known to scratch and dig into flexible ureteroscope liners, causing damage and/or hanging up and snapping off. ProFlex™ Laser Fiber tips have rounded edges so that there is no sharp edge to scratch or dig into the soft ureteroscope liner and the shorter exposed fiber length reduces the risk of tip detachment.
Substantial Equivalence:
A direct comparison of key characteristics demonstrates that ProFlex laser fibers are substantially equivalent to both predicate devices in terms of materials of construction, intended uses, technological considerations and performance characteristics. ProFlex™ Laser Fibers are as safe, as effective and perform as well as the predicate devices.
The performance of ProFlex™ 200 fibers were compared to SureFlex™ LLF200TG for the 200um core fiber design because, to our knowledge, SureFlex™ LLF200TG is the only true 200µm core fiber available on the market. The ProFlex 273 fibers were compared to Laser Peripherals HB200 because it is a readily available fiber, commonly used within the intended market and the Laser Peripherals' HB200 - identified as "Holmium Laser Fiber 200 micron" on the label -- is actually a 273µm core fiber where the fiber raw material is substantially equivalent to the ProFlex™ 273 base fiber material to which it is rationally compared. ProFlex's technology is also fairly well bracketed between the two chosen predicate devices.
Performance Testing (Bench and User Evaluation):
Briefly, subject and predicate fibers were power tested in relaxed and strained (bending) configurations using a cleared surgical holmium laser. ProFlex™ Laser Fibers performed better than the predicate devices in all
7
four cases -- 200µm core ProFlex™ versus 200µm core SureFlex™, relaxed and stressed, and 273um core ProFlex™ versus 273um core Laser Peripherals, relaxed and stressed - individually, on average and in consistency. Accordingly, ProFlex™ fibers are determined to be as safe and as effective as the predicate devices. ProFlex has also been evaluated by one OEM holmium laser manufacturer and found to preform well.
Manufacturing, Packaging and Sterilization Facility:
Proflex™ Laser Fibers are designed, manufactured, packaging and sterilized within the same facility, the same model EtO sterilizer and with the same personnel that originally produced the SureFlex™ and AccuFlex™ Laser Fiber predicate devices, and their predecessors through 2008. While the manufacturing equipment is mostly new, it is substantially equivalent to the equipment used to make the predicate SureFlex™ and AccuFlex™ Laser Fibers, is validated to perform the processes for which they are intended.